235 related articles for article (PubMed ID: 12734305)
1. Growing pains: central review board project still developing.
Randal J
J Natl Cancer Inst; 2003 May; 95(9):636-7. PubMed ID: 12734305
[No Abstract] [Full Text] [Related]
2. Who watches the watchmen?
Nature; 2011 Aug; 476(7359):125. PubMed ID: 21833048
[No Abstract] [Full Text] [Related]
3. Clinical Trials, Healthy Controls, and the Birth of the IRB.
Stark L; Greene JA
N Engl J Med; 2016 Sep; 375(11):1013-5. PubMed ID: 27626515
[No Abstract] [Full Text] [Related]
4. Cancer trials and the Institutional Review Board (IRB).
Kurtzman S; Lazzarini Z
Cancer Treat Res; 2007; 132():11-30. PubMed ID: 17305015
[No Abstract] [Full Text] [Related]
5. Extend the reach of institutional review boards first, then strengthen their depth.
Spike J
Am J Bioeth; 2008 Nov; 8(11):11-2. PubMed ID: 19061097
[No Abstract] [Full Text] [Related]
6. Institutionalisation of Bulgarian ethics committees: history and current status.
Krastev Y
Indian J Med Ethics; 2011; 8(3):148-51. PubMed ID: 22106639
[TBL] [Abstract][Full Text] [Related]
7. A central institutional review board for multi-institutional trials.
Christian MC; Goldberg JL; Killen J; Abrams JS; McCabe MS; Mauer JK; Wittes RE
N Engl J Med; 2002 May; 346(18):1405-8. PubMed ID: 11986418
[No Abstract] [Full Text] [Related]
8. The paradoxical problem with multiple-IRB review.
Menikoff J
N Engl J Med; 2010 Oct; 363(17):1591-3. PubMed ID: 20942660
[No Abstract] [Full Text] [Related]
9. Toward protecting the safety of participants in clinical trials.
Califf RM; Morse MA; Wittes J; Goodman SN; Nelson DK; DeMets DL; Iafrate RP; Sugarman J
Control Clin Trials; 2003 Jun; 24(3):256-71. PubMed ID: 12757992
[TBL] [Abstract][Full Text] [Related]
10. [Ethics of observational studies: are specific rules useful?].
Rosmini F
Epidemiol Prev; 2006; 30(4-5):295-7. PubMed ID: 17176945
[No Abstract] [Full Text] [Related]
11. The ethics approval process for multisite research studies in Australia: changes sought by the Australian Genomics initiative.
Haas MA; Boughtwood TF; Quinn MC;
Med J Aust; 2019 Nov; 211(10):440-444.e1. PubMed ID: 31734945
[No Abstract] [Full Text] [Related]
12. Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.
Vardeny O; Hernandez AF; Cohen LW; Franklin A; Baqai M; Palmer S; Bierer BE; Cobb N
Clin Trials; 2019 Jun; 16(3):290-296. PubMed ID: 30866676
[TBL] [Abstract][Full Text] [Related]
13. Improving protection for research subjects.
Steinbrook R
N Engl J Med; 2002 May; 346(18):1425-30. PubMed ID: 11986426
[No Abstract] [Full Text] [Related]
14. Introduction to special issue of Accountability in Research on the review and approval of biomedical research proposals: a call for a centralized national human research protections system.
Mann H; Shamoo AE
Account Res; 2006; 13(1):1-9. PubMed ID: 16770856
[No Abstract] [Full Text] [Related]
15. Protecting human subjects in the NIH's Intramural Research Program: a draft instrument to evaluate convened meetings of its IRBs.
Wichman A; Kalyan DN; Abbott LJ; Wesley R; Sandler AL
IRB; 2006; 28(3):7-10. PubMed ID: 17036438
[No Abstract] [Full Text] [Related]
16. Making pragmatism practicable for the institutional review board.
Robertson C
Am J Bioeth; 2008 Apr; 8(4):49-51. PubMed ID: 18576258
[No Abstract] [Full Text] [Related]
17. The sex kitten of bioethics? Research ethics comes of age.
Resink DB
Hastings Cent Rep; 2008; 38(5):5-6. PubMed ID: 18949856
[No Abstract] [Full Text] [Related]
18. Improving protection for human research subjects: better oversight, not just more oversight.
Schluger NW
Am J Bioeth; 2008 Nov; 8(11):13-5. PubMed ID: 19061098
[No Abstract] [Full Text] [Related]
19. Canadian research ethics boards and multisite research: experiences from two minimal-risk studies.
Racine E; Bell E; Deslauriers C
IRB; 2010; 32(3):12-8. PubMed ID: 20590052
[No Abstract] [Full Text] [Related]
20. Would central review streamline the clinical trials process?
Reynolds T
J Natl Cancer Inst; 2002 Oct; 94(20):1519. PubMed ID: 12381700
[No Abstract] [Full Text] [Related]
[Next] [New Search]
